Updated:
Odonate Therapeutics, Inc.
Odonate Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001717452, and its reported...
Overview
Odonate Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001717452, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2021-02-23, it reported net income of USD -126,350,000; total assets of USD 167,886,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Odonate Therapeutics, Inc.
- Former names in filing history
- Odonate Therapeutics, LLC (2017-09-29 to 2017-12-06)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- New York, NY, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001717452
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Operating cash flow |
|---|---|---|---|---|
| FY2020USD | -$126.3M | $167.9M | -$113.1M | |
| FY2019USD | -$111.8M | $188.8M | -$96.6M | |
| FY2018USD | -$89.0M | $142.7M | -$67.1M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| SC 13G | — | NONE | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| SC 13G | — | Form SC 13G | |
| SC 13G | — | SC 13G | |
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Odonate Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.